Discovery of an Oral Potent Selective Inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS)

Chris P. Carron, John I. Trujillo, Kirk L. Olson, Wei Huang, Bruce C. Hamper, Tom Dice, Bradley E. Neal, Matthew J. Pelc, Jacqueline E. Day, Douglas C. Rohrer, James R. Kiefer, Joseph B. Moon, Barbara A. Schweitzer, Tanisha D. Blake, Steve R. Turner, Rhonda Woerndle, Brenda L. Case, Christine P. Bono, Vickie M. Dilworth, Christie L. Funckes-ShippyBecky L. Hood, Gina M. Jerome, Christine M. Kornmeier, Melissa R. Radabaugh, Melanie L. Williams, Michael S. Davies, Craig D. Wegner, Dean J. Welsch, William M. Abraham, Chad J. Warren, Martin E. Dowty, Fengmei Hua, Anup Zutshi, Jerry Z. Yang, Atli Thorarensen

Research output: Contribution to journalArticlepeer-review

Original languageAmerican English
JournalACS Medicinal Chemistry Letters
Volume1
DOIs
StatePublished - May 13 2010

Keywords

  • Hematopoietic prostaglandin D synthase (HPGDS)
  • PGH2
  • PGD2
  • airway allergy
  • inflammatory processes
  • cyclooxygenase (COX)

Disciplines

  • Biology
  • Pharmacology
  • Biochemistry
  • Immunology and Infectious Disease

Cite this